Daniel A. Holterman

789 total citations · 1 hit paper
12 papers, 631 citations indexed

About

Daniel A. Holterman is a scholar working on Immunology, Surgery and Oncology. According to data from OpenAlex, Daniel A. Holterman has authored 12 papers receiving a total of 631 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 4 papers in Surgery and 4 papers in Oncology. Recurrent topics in Daniel A. Holterman's work include Immunotherapy and Immune Responses (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and CAR-T cell therapy research (2 papers). Daniel A. Holterman is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and CAR-T cell therapy research (2 papers). Daniel A. Holterman collaborates with scholars based in United States, Bosnia and Herzegovina and United Kingdom. Daniel A. Holterman's co-authors include Carrie Snyder, Henry T. Lynch, Nianqing Xiao, Zoran Gatalica, Omid Hamid, Inga Rose, Gargi D. Basu, Anatole Ghazalpour, Daniel D. Von Hoff and Todd Maney and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Cancer.

In The Last Decade

Daniel A. Holterman

12 papers receiving 626 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Programmed Cell Death 1 (PD-1) and Its Ligand (PD-L1) in Common Cancers and Their Correlation with Molecular Cancer Type

2014 416 citations Zoran Gatalica, Carrie Snyder et al. Cancer Epidemiology Biomarkers & Prevention profile →

Peers

Daniel A. Holterman

ONCOL

IMMUN

PRM

Annegé Vledder Netherlands

Véronique Catros France

Charlene M. Fares United States

George Vlahos Greece

Joël Gsponer Switzerland

Yiming Li China

Micaela Morgado United States

Walter M. Klein United States

Gulidanna Shayan United States

Annegé Vledder Netherlands

Daniel A. Holterman

404 ×1.0

ONCOL

307 ×1.3

IMMUN

126 ×0.7

PRM

139 ×1.3

103 ×1.1

Citations per year, relative to Daniel A. Holterman Daniel A. Holterman (= 1×) peers Annegé Vledder

Countries citing papers authored by Daniel A. Holterman

Since Specialization

Citations

This map shows the geographic impact of Daniel A. Holterman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel A. Holterman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel A. Holterman more than expected).

Fields of papers citing papers by Daniel A. Holterman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel A. Holterman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel A. Holterman. The network helps show where Daniel A. Holterman may publish in the future.

Co-authorship network of co-authors of Daniel A. Holterman

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel A. Holterman. A scholar is included among the top collaborators of Daniel A. Holterman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel A. Holterman. Daniel A. Holterman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Gatalica, Zoran, Carrie Snyder, Kimberly Yeatts, et al.. (2014). Programmed death 1 (PD-1) lymphocytes and ligand (PD-L1) in colorectal cancer and their relationship to microsatellite instability status.. Journal of Clinical Oncology. 32(15_suppl). 3625–3625. 16 indexed citations

Gatalica, Zoran, Carrie Snyder, Todd Maney, et al.. (2014). Programmed Cell Death 1 (PD-1) and Its Ligand (PD-L1) in Common Cancers and Their Correlation with Molecular Cancer Type. Cancer Epidemiology Biomarkers & Prevention. 23(12). 2965–2970. 416 indexed citations breakdown →

Gatalica, Zoran, Anatole Ghazalpour, Daniel A. Holterman, et al.. (2014). Programmed cell death 1 (PD-1) and its ligand (PD-L1) in common cancers and their correlation with molecular cancer type.. Journal of Clinical Oncology. 32(15_suppl). e22091–e22091. 6 indexed citations

Holterman, Daniel A., et al.. (2012). Abstract 3607: Differential protein expression and miR content of sorted subsets of circulating microvesicles from cancer patients and healthy controls. Cancer Research. 72(8_Supplement). 3607–3607. 4 indexed citations

Holterman, Daniel A., José I. Diaz, P F Blackmore, et al.. (2006). Overexpression of α-defensin is associated with bladder cancer invasiveness. Urologic Oncology Seminars and Original Investigations. 24(2). 97–108. 41 indexed citations

Ciavarra, Richard P., Daniel A. Holterman, William F. Glass, et al.. (2003). Impact of the tumor microenvironment on host infiltrating cells and the efficacy of flt3-ligand combination immunotherapy evaluated in a treatment model of mouse prostate cancer. Cancer Immunology Immunotherapy. 52(9). 535–545. 18 indexed citations

Somers, Kenneth D., Daniel A. Holterman, Nazita Yousefieh, et al.. (2003). Orthotopic treatment model of prostate cancer and metastasis in the immunocompetent mouse: Efficacy of flt3 ligand immunotherapy. International Journal of Cancer. 107(5). 773–780. 29 indexed citations

Ciavarra, Richard P., Daniel A. Holterman, Nazita Yousefieh, et al.. (2003). Prostate Tumor Microenvironment Alters Immune Cells and Prevents Long-Term Survival in an Orthotopic Mouse Model Following flt3-Ligand/CD40-Ligand Immunotherapy. Journal of Immunotherapy. 27(1). 13–26. 19 indexed citations

Bhargava, Parul, Glenn M. Eisen, Daniel A. Holterman, et al.. (2000). Endoscopic Mapping and Surrogate Markers for Better Surveillance in Barrett Esophagus. American Journal of Clinical Pathology. 114(4). 552–563. 19 indexed citations

10.

Montgomery, Elizabeth A., et al.. (1996). Barrett Esophagus With Dysplasia:Flow Cytometric DNA Analysis of Routine, Paraffin-Embedded Mucosal Biopsies. American Journal of Clinical Pathology. 106(3). 298–304. 30 indexed citations

11.

Sobel, Douglas O., Norio Azumi, Karen Creswell, et al.. (1995). The role of NK cell activity in the pathogenesis of poly I:C accelerated and spontaneous diabetes in the diabetes prone BB rat. Journal of Autoimmunity. 8(6). 843–857. 9 indexed citations

12.

Naylor, Paul H., Marcelo B. Sztein, Scott H. Maurer, et al.. (1991). Preclinical and clinical studies on immunogenicity and safety of the HIV-1 p17-based synthetic peptide AIDS vaccine — HGP-30-KLH. International Journal of Immunopharmacology. 13. 117–127. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact